Pegylated Human Granulocyte Colony-stimulating Factor Injection

北京双鹭药业股份有限公司🇨🇳 National Medical Products Administration

Approval Id: 8UZJM5acEL2
Approval Number: 国药准字S20230049
Generic Name: 聚乙二醇化重组人粒细胞刺激因子注射液
Generic Name En: Pegylated Human Granulocyte Colony-stimulating Factor Injection
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 1.0ml：1.0mg（7×10^7 IU）
Reg Date: 2023-09-19
Company Name: 北京双鹭药业股份有限公司
Company Address: 北京市海淀区阜石路69号碧桐园1号楼4层
Production Company Name: 北京双鹭药业股份有限公司
Production Company Address: 北京市石景山区八大处高科技园区中园路9号
Company Detail Path: /organization/beijing-sl-pharmaceutical-co-ltd
Production Company Detail Path: /organization/beijing-sl-pharmaceutical-co-ltd

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 19, 2023

Approval ID

8UZJM5acEL2

Type

生物制品